Skip to content

Intravenous Terbutaline to Facilitate Labor Epidural Catheter Placement

Intravenous Terbutaline to Facilitate Epidural Catheter Placement for Parturients With Labor Pain

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01651962
Enrollment
250
Registered
2012-07-27
Start date
2012-08-31
Completion date
2015-12-31
Last updated
2015-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labor Pain

Keywords

Labor Pain, Analgesia, Epidural

Brief summary

Labor pain is a major factor in making the placement of an epidural catheter difficult. The epidural, once in place and dosed, eventually decreases the parturient's pain. To achieve this goal as fast and safely as possible it would be helpful to have a parturient who can tolerate and co-operate with the placement of the epidural catheter. Briefly stopping contractions, the cause of labor pain, could be the key to achieve this goal. This study will evaluate the safety, efficacy and duration of the drug terbutaline for this purpose.

Interventions

DRUGFentanyl
DRUG0.9% NaCl

Sponsors

Kai Schoenhage
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 53 Years
Healthy volunteers
No

Inclusion criteria

* in labor * labor pain \>3 on visual analog scale (VAS)

Exclusion criteria

* cardiovascular disease * preeclampsia * diabetes mel-litus * thyroid disease * current (outpatient) opioid medication * recent and / or current use of cocaine * seizure disorder * psychiatric disease * body mass index \>35 * preterm labor (\<37 weeks pregnant) * known allergies to any of the three study substances

Design outcomes

Primary

MeasureTime frameDescription
reduction of pain score on a visual analog scale (VAS) of 1-100-30 minutessemi-quantitative assessment of decrease in the subject's pain score after administration of the study drug for the placement of an epidural catheter

Secondary

MeasureTime frameDescription
movement during epidural placement0-30 minutessemi-quantitative assessment of the subject's movement during placement of the epidural catheter: 0-1-2-3: none - extremities - trunk a bit - trunk a lot
position during epidural placement0-30 minutessemi-quantitative assessment of the subject's position during the epidural catheter placement: 0-1-2: excellent - moderate - poor

Other

MeasureTime frameDescription
hemodynamic and oxygenation assessment of parturient and fetus, side effects0-30 minutesheart rate (HR), non-invasive blood pressure (NIBP), pulse-oximetry (SpO2), fetal heart rate (FHR), uterine contractions (CTG - cardiotocogram); feeling of being jittery, pruritus and nausea

Countries

United States

Contacts

Primary ContactKai Schoenhage, MD
kschoenhage@anesth.arizona.edu(520) 626-7221

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026